Bruins Slot L, Colpaert F
J Neurosci. 1999; 19(23):10520-9.
PMID: 10575048
PMC: 6782434.
McMillan D
Psychopharmacology (Berl). 1982; 78(2):131-4.
PMID: 6817368
DOI: 10.1007/BF00432249.
Holtzman S
Psychopharmacology (Berl). 1982; 77(4):295-300.
PMID: 6813889
DOI: 10.1007/BF00432758.
White F, Appel J
Psychopharmacology (Berl). 1982; 76(1):20-5.
PMID: 6805003
DOI: 10.1007/BF00430748.
Herling S, Coale Jr E, Hein D, Winger G, Woods J
Psychopharmacology (Berl). 1981; 73(3):286-91.
PMID: 6787651
DOI: 10.1007/BF00422419.
Discriminative stimulus effects of etorphine in Rhesus monkeys.
Herling S, Woods J
Psychopharmacology (Berl). 1981; 72(3):265-7.
PMID: 6784144
DOI: 10.1007/BF00431828.
Effects of barbiturates and other sedative hypnotics in pigeons trained to discriminate phencyclidine from saline.
McMillan D, Wenger G
J Exp Anal Behav. 1983; 40(2):133-42.
PMID: 6631312
PMC: 1347903.
DOI: 10.1901/jeab.1983.40-133.
Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.
White J, Holtzman S
Psychopharmacology (Berl). 1983; 80(1):1-9.
PMID: 6408661
DOI: 10.1007/BF00427484.
Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern.
Quirion R, Bowen W, Herkenham M, Pert C
Cell Mol Neurobiol. 1982; 2(4):333-46.
PMID: 6305502
PMC: 11572859.
DOI: 10.1007/BF00710853.
Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
Shearman G, Herz A
Psychopharmacology (Berl). 1982; 78(1):63-6.
PMID: 6292982
DOI: 10.1007/BF00470590.
Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques.
Young A, Stephens K
Psychopharmacology (Berl). 1984; 84(3):356-61.
PMID: 6151208
DOI: 10.1007/BF00555213.
Drug discrimination training with a single choice trial per session.
Tomie A, Loukas E, Stafford I, Peoples L, Wagner G
Psychopharmacology (Berl). 1985; 86(1-2):217-22.
PMID: 3927359
DOI: 10.1007/BF00431713.
Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites.
Middaugh L, Favara J, Boggan W, Stringer A
Psychopharmacology (Berl). 1988; 96(3):381-4.
PMID: 3146772
DOI: 10.1007/BF00216066.
Effects of single or multiple choice trials per session on drug discrimination performance.
Tomie A, Peoples L, Wagner G
Psychopharmacology (Berl). 1987; 92(4):529-35.
PMID: 3114806
DOI: 10.1007/BF00176490.
Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
Colpaert F, Janssen P
Psychopharmacology (Berl). 1986; 90(2):222-8.
PMID: 3097702
DOI: 10.1007/BF00181246.
Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands.
Contreras P, Monahan J, Lanthorn T, Pullan L, DiMaggio D, Handelmann G
Mol Neurobiol. 1987; 1(3):191-211.
PMID: 2855791
DOI: 10.1007/BF02936608.
Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
Locke K, Gorney B, Cornfeldt M, Fielding S
Psychopharmacology (Berl). 1989; 99(4):492-6.
PMID: 2556726
DOI: 10.1007/BF00589897.
Biologically active MK-801 and SKF-10,047 binding sites distinct from those in rat brain are expressed on human lung cancer cells.
Maneckjee R, Minna J
Mol Biol Cell. 1992; 3(6):613-9.
PMID: 1323349
PMC: 275617.
DOI: 10.1091/mbc.3.6.613.
